Collaboration

Biomanufacturing@MIT-CBI provides forums to collaboratively address complex issues and innovate solutions
 for manufacturing biologic medicines, ensuring 
that they are accessible to all patients who need them.

BioACCESS is an initiative aimed at enabling global access to biologic therapies, especially for non-communicable diseases in resource-constrained settings, through innovative approaches to systems analysis, technology development, policy design, and education.

BioMAN seeks to develop new knowledge, science, technologies and strategies that advance the manufacture and global delivery of high-quality biopharmaceuticals.

The mission of the CAACB is to pool biopharmaceutical manufacturing expertise in the area of adventitious agent contamination to better enable the safe and reliable delivery of life saving biologics.

Meet the people who create these vibrant programs.